Drugs / LX6171
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00691808 | Feb → Oct 2008 | amnestic disorder | Lexicon Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LX6171 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00691808 ↗ |
| Route | Oral | “daily oral intake for 28 days” NCT00691808 ↗ |